QCM
MRVI icon

QRG Capital Management’s Maravai LifeSciences MRVI Stock Holding History

QRG Capital Management’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-17,143
Closed -$149K – 1067
2024
Q1 		$149K Buy
17,143
+1,796
+12% +$12.2K ﹤0.01% 1036
2023
Q4 		$101K Buy
15,347
+1,093
+8% +$7.06K ﹤0.01% 1010
2023
Q3 		$143K Buy
+14,254
New +$157K ﹤0.01% 942

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

QRG Capital Management's MRVI Position: Q2 2024 in Review

QRG Capital Management sold out of Maravai LifeSciences (MRVI) in Q2 2024, closing a stake of 17,143 shares — an estimated $149K sold.

QRG Capital Management first reported a position in MRVI in Q3 2023 and held it in 3 quarters. The position peaked at $149K in Q1 2024. 206 funds tracked by Wall St. Rank hold MRVI as of Q2 2024.

  • QRG Capital Management reported no remaining Maravai LifeSciences position as of Q2 2024 after selling out during the quarter.
  • QRG Capital Management sold 17,143 Maravai LifeSciences shares in Q2 2024, an estimated $149K.
  • QRG Capital Management first reported a position in Maravai LifeSciences in Q3 2023 and held it in 3 quarters.
  • QRG Capital Management's Maravai LifeSciences position peaked at $149K in Q1 2024.
  • 206 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q2 2024.

Based on QRG Capital Management's 13F filing for Q2 2024, filed 12 Jul 2024.